IFN-γ increases susceptibility to influenza A infection through suppression of group II innate lymphoid cells.

IFN-γ increases susceptibility to influenza A infection through suppression of group II innate lymphoid cells.
复制标题

DOI:
10.1038/mi.2017.41
复制
发表时间:
2018-01
期刊:
影响因子:
8
通讯作者:
Metzger DW
Metzger DW
中科院分区:
医学1区
文献类型:
--
作者:
Califano D;Furuya Y;Roberts S;Avram D;McKenzie ANJ;Metzger DW

文献摘要

参考文献

被引文献

相似文献

在流感病毒感染后,呼吸道中经常观察到干扰素-γ水平升高,但其潜在作用尚不清楚。我们现在证明,流感诱导的干扰素-γ在受到大流行H1N1 A/CA/04/2009流感病毒的攻击后,限制了肺内天然淋巴细胞组II(ILC2)的保护性功能。具体地说,干扰素-γ缺乏导致ILC2活性增强,其特征是IL-5和两用调节素的产生增加,组织完整性改善,但ILC2数量、病毒载量或清除没有变化。我们进一步发现,干扰素-γ缺陷小鼠以及中和抗干扰素-γ抗体处理的野生型动物,对H1N1 A/CA/04/2009流感病毒的致死性感染的易感性降低,而且生存依赖于IL-5的存在。在ILC2缺陷的动物中未观察到干扰素-γ中和的有益效果。这些数据支持新的概念,即干扰素-γ可以通过限制ILC2的活性在流感的发病机制中发挥有害作用。因此,ILC2活性的调节是流感感染后治疗的潜在靶点。
Increased levels of IFN-γ are routinely observed in the respiratory tract following influenza virus infection, yet its potential role remains unclear. We now demonstrate that influenza-induced IFN-γ restricts protective innate lymphoid cell group II (ILC2) function in the lung following challenge with the pandemic H1N1 A/CA/04/2009 influenza virus. Specifically, IFN-γ deficiency resulted in enhanced ILC2 activity, characterized by increased production of IL-5 and amphiregulin, and improved tissue integrity, yet no change in ILC2 numbers, viral load or clearance. We further found that IFN-γ-deficient mice, as well as wild-type animals treated with neutralizing anti-IFN-γ antibody, exhibited decreased susceptibility to lethal infection with H1N1 A/CA/04/2009 influenza virus, and moreover that survival was dependent on the presence of IL-5. The beneficial effects of IFN-γ neutralization were not observed in ILC2-deficient animals. These data support the novel concept that IFN-γ can play a detrimental role in the pathogenesis of influenza through a restriction in ILC2 activity. Thus, regulation of ILC2 activity is a potential target for post-infection therapy of influenza.
在流感病毒感染过程中,第2组IL-5的先天淋巴样细胞的产生受NKT细胞的调节。
DOI: 10.1371/journal.ppat.1003615
发表时间: 2013-09
期刊: PLoS pathogens
影响因子: 6.7
作者:
Gorski SA;Hahn YS;Braciale TJ
通讯作者: Braciale TJ
DOI: 10.1016/j.immuni.2015.07.005
发表时间: 2015-08-18
期刊: Immunity
影响因子: 32.4
作者:
Califano D;Cho JJ;Uddin MN;Lorentsen KJ;Yang Q;Bhandoola A;Li H;Avram D
通讯作者: Avram D
DOI: 10.1016/j.jaci.2011.09.041
发表时间: 2012-01-01
影响因子: 14.2
作者:
Barlow, Jillian L.;Bellosi, Agustin;McKenzie, Andrew N. J.
通讯作者: McKenzie, Andrew N. J.
DOI: 10.1084/jem.20121964
发表时间: 2013-03-11
期刊: The Journal of experimental medicine
影响因子: --
作者:
Molofsky AB;Nussbaum JC;Liang HE;Van Dyken SJ;Cheng LE;Mohapatra A;Chawla A;Locksley RM
通讯作者: Locksley RM
DOI: 10.4049/jimmunol.0803109
发表时间: 2009-10-15
期刊: Journal of immunology (Baltimore, Md. : 1950)
影响因子: --
作者:
Durrant DM;Gaffen SL;Riesenfeld EP;Irvin CG;Metzger DW
通讯作者: Metzger DW